| Profile | GDS5822 / ILMN_2621021 |
| Title | Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model |
| Organism | Mus musculus |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1276599 | PDAC Late Ablation Control 1 | 43.7 | 68 |
| GSM1276600 | PDAC Late Ablation Control 2 | 69.1 | 72 |
| GSM1276601 | PDAC Late Ablation Control 3 | 31.6 | 59 |
| GSM1276602 | PDAC Late Ablation 1 | 37.2 | 67 |
| GSM1276603 | PDAC Late Ablation 2 | 46.8 | 68 |
| GSM1276604 | PDAC Late Ablation 3 | 49.3 | 68 |
| GSM1303940 | PDAC Late Ablation_anti-CTLA4 1 | 35.8 | 66 |
| GSM1303941 | PDAC Late Ablation_anti-CTLA4 2 | 44.7 | 64 |
| GSM1303942 | PDAC Late Ablation_anti-CTLA4 3 | 44.4 | 63 |